Your browser doesn't support javascript.
loading
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
Invernizzi, Rachele; Wu, Benjamin G; Barnett, Joseph; Ghai, Poonam; Kingston, Shaun; Hewitt, Richard J; Feary, Johanna; Li, Yonghua; Chua, Felix; Wu, Zhe; Wells, Athol U; George, Peter M; Renzoni, Elisabetta A; Nicholson, Andrew G; Rice, Alexandra; Devaraj, Anand; Segal, Leopoldo N; Byrne, Adam J; Maher, Toby M; Lloyd, Clare M; Molyneaux, Philip L.
Afiliación
  • Invernizzi R; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Wu BG; Division of Pulmonary and Critical Care Medicine, New York University, New York, New York; and.
  • Barnett J; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Ghai P; Royal Brompton Hospital, London, United Kingdom.
  • Kingston S; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Hewitt RJ; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Feary J; Royal Brompton Hospital, London, United Kingdom.
  • Li Y; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Chua F; Royal Brompton Hospital, London, United Kingdom.
  • Wu Z; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Wells AU; Royal Brompton Hospital, London, United Kingdom.
  • George PM; Division of Pulmonary and Critical Care Medicine, New York University, New York, New York; and.
  • Renzoni EA; Royal Brompton Hospital, London, United Kingdom.
  • Nicholson AG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Rice A; Royal Brompton Hospital, London, United Kingdom.
  • Devaraj A; Royal Brompton Hospital, London, United Kingdom.
  • Segal LN; Royal Brompton Hospital, London, United Kingdom.
  • Byrne AJ; Royal Brompton Hospital, London, United Kingdom.
  • Maher TM; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Lloyd CM; Royal Brompton Hospital, London, United Kingdom.
  • Molyneaux PL; Royal Brompton Hospital, London, United Kingdom.
Am J Respir Crit Care Med ; 203(3): 339-347, 2021 02 01.
Article en En | MEDLINE | ID: mdl-32692582
ABSTRACT
Rationale Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in the lower airways in CHP.

Objectives:

To characterize and compare the airway microbiome in subjects with CHP, subjects with idiopathic pulmonary fibrosis (IPF), and control subjects.

Methods:

We prospectively recruited individuals with a CHP diagnosis (n = 110), individuals with an IPF diagnosis (n = 45), and control subjects (n = 28). Subjects underwent BAL and bacterial DNA was isolated, quantified by quantitative PCR and the 16S ribosomal RNA gene was sequenced to characterize the bacterial communities in the lower airways.Measurements and Main

Results:

Distinct differences in the microbial profiles were evident in the lower airways of subjects with CHP and IPF. At the phylum level, the prevailing microbiota of both subjects with IPF and subjects with CHP included Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. However, in IPF, Firmicutes dominated, whereas the percentage of reads assigned to Proteobacteria in the same group was significantly lower than the percentage found in subjects with CHP. At the genus level, the Staphylococcus burden was increased in CHP, and Actinomyces and Veillonella burdens were increased in IPF. The lower airway bacterial burden in subjects with CHP was higher than that in control subjects but lower than that of those with IPF. In contrast to IPF, there was no association between bacterial burden and survival in CHP.

Conclusions:

The microbial profile of the lower airways in subjects with CHP is distinct from that of IPF, and, notably, the bacterial burden in individuals with CHP fails to predict survival.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ADN Bacteriano / Fibrosis Pulmonar Idiopática / Alveolitis Alérgica Extrínseca / Microbiota / Pulmón Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ADN Bacteriano / Fibrosis Pulmonar Idiopática / Alveolitis Alérgica Extrínseca / Microbiota / Pulmón Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido